Would have been nice (very very nice) but Im glad that management are focussed on getting commercial operations profitable.
Next big review has to be the medical devices/respiratory product line. If they can't generate profits with the number of distribution channels they have now then they will never generate a profit.
Now is the time to focus on the bottom line and not the top line.
Ann: MVP concludes CSIRO API Continuous Flow Technology Project, page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.005(1.10%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 45.5¢ | 45.0¢ | $46.15K | 101.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36411 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 7129 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |